{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T00:53:48Z","timestamp":1720745628885},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2000,11]]},"DOI":"10.3816\/clm.2000.s.003","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T01:01:57Z","timestamp":1221181317000},"page":"S15-S20","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Treatment of Cutaneous T-Cell Lymphoma from a Dermatologist's Perspective"],"prefix":"10.3816","volume":"1","author":[{"given":"Madeleine","family":"Duvic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2000.s.003_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/1523-1747.ep12389114","article-title":"Detection of clonal T-cell receptor gamma gene rearrangements in early mycosis fungoides\/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR\/DGGE)","volume":"103","author":"Wood","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib2","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0190-9622(08)80970-X","article-title":"T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders","volume":"25","author":"Zelickson","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"key":"10.3816\/CLM.2000.s.003_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<208::AID-CNCR28>3.0.CO;2-2","article-title":"The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States","volume":"85","author":"Weinstock","year":"1999","journal-title":"Cancer"},{"key":"10.3816\/CLM.2000.s.003_bib5","first-page":"172","article-title":"Cutaneous lymphomas other than mycosis fungoides","volume":"13","author":"Joly","year":"1994","journal-title":"Semin Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib6","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(93)70140-O","article-title":"Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment","volume":"28","author":"Willemze","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib7","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1523-1747.ep12363352","article-title":"HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma","volume":"107","author":"Jackow","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib8","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1038\/jid.1995.29","article-title":"Analysis of HLA-D locus alleles in alopecia areata patients and families","volume":"104","author":"Duvic","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib9","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/40166","article-title":"Cutaneous lymphocyte antigen is a specialized form of PSGL-1 expressed on skin-homing T cells","volume":"389","author":"Fuhlbrigge","year":"1997","journal-title":"Nature"},{"key":"10.3816\/CLM.2000.s.003_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood.V86.2.651.bloodjournal862651","article-title":"Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?","volume":"86","author":"Sarris","year":"1995","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.003_bib11","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1016\/S0140-6736(86)91502-3","article-title":"Psoriasis and alpha-interferon","volume":"1","author":"Quesada","year":"1986","journal-title":"Lancet"},{"key":"10.3816\/CLM.2000.s.003_bib12","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-121-8-199410150-00007","article-title":"Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sezary syndrome)","volume":"121","author":"Bunn","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.3816\/CLM.2000.s.003_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/10428199809068568","article-title":"Tumor necrosis factor-alpha and interferon-gamma, but not HTLV-I tax, are likely factors in the epidermotropism of cutaneous T-cell lymphoma via induction of interferoninducible protein-10","volume":"29","author":"Daliani","year":"1998","journal-title":"Leuk Lymphoma"},{"key":"10.3816\/CLM.2000.s.003_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1182\/blood.V89.1.32","article-title":"Association of erythrodermic cutaneous T-cell lymphoma, superantigen-positive Staphylococcus aureus, and oligoclonal T-cell receptor V beta gene expansion","volume":"89","author":"Jackow","year":"1997","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.003_bib16","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1172\/JCI116711","article-title":"Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens","volume":"92","author":"Leung","year":"1993","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2000.s.003_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/1523-1747.ep12468941","article-title":"A potential role for superantigens in the pathogenesis of psoriasis","volume":"100","author":"Leung","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib18","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1038\/jid.1995.8","article-title":"The role of superantigens in skin disease","volume":"105","author":"Leung","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib19","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2000.s.003_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1001\/archderm.135.1.26","article-title":"Clinical characteristics and longterm outcome of patients with generalized patch and\/or plaque (T2) mycosis fungoides","volume":"135","author":"Kim","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0889-8588(18)30057-1","article-title":"Topical treatment of early cutaneous T-cell lymphoma","volume":"9","author":"Ramsay","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2000.s.003_bib22","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0360-3016(98)00517-3","article-title":"Total skin electron beam therapy with or without adjuvant topical nitrogen mustard or nitrogen mustard alone as initial treatment of T2 and T3 mycosis fungoides","volume":"43","author":"Chinn","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CLM.2000.s.003_bib23","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1001\/archderm.1975.01630240020003","article-title":"Treatment of mycosis fungoides with topical nitrosourea compounds: Further studies","volume":"111","author":"Zackheim","year":"1975","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib24","first-page":"4","article-title":"Phase I-II trial of Targretin gel for the skin-directed topical treatment of patients with cutaneous T-cell lymphoma","volume":"114","author":"Kuzel","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0162-3109(98)00012-5","article-title":"Effects of a novel purine nucleoside phosphorylase inhibitor, BCX-34, on activation and proliferation of normal human lymphoid cells","volume":"40","author":"Conry","year":"1998","journal-title":"Immunopharmacology"},{"key":"10.3816\/CLM.2000.s.003_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1046\/j.1523-1747.1998.00278.x","article-title":"Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders","volume":"111","author":"Fox","year":"1998","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib27","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/bjc.1998.694","article-title":"Ultraviolet radiation and cutaneous lymphoma","volume":"78","author":"Zackheim","year":"1998","journal-title":"Br J Cancer"},{"key":"10.3816\/CLM.2000.s.003_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1440-0960.1997.tb01090.x","article-title":"Photochemotherapy for mycosis fungoides: current status","volume":"38","author":"Watson","year":"1997","journal-title":"Australas J Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib29","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199704103361501","article-title":"Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study","volume":"336","author":"Stern","year":"1997","journal-title":"N Engl J Med"},{"key":"10.3816\/CLM.2000.s.003_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1200\/JCO.1995.13.1.257","article-title":"Effectiveness of interferon alfa-2a combined with phototherapy for mycosis fungoides and the Sezary syndrome","volume":"13","author":"Kuzel","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.s.003_bib31","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1084\/jem.182.6.2057","article-title":"Successful ultraviolet B treatment of psoriasis is accompanied by a reversal of keratinocyte pathology and by selective depletion of intraepidermal T cells","volume":"182","author":"Krueger","year":"1995","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2000.s.003_bib32","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1751-1097.1997.tb08658.x","article-title":"An unexpected spectrum of p53 mutations from squamous cell carcinomas in psoriasis patients treated with PUVA","volume":"66","author":"Wang","year":"1997","journal-title":"Photochem Photobiol"},{"key":"10.3816\/CLM.2000.s.003_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2133.1995.tb02488.x","article-title":"p53 protein expression in cutaneous T-cell lymphomas","volume":"133","author":"Lauritzen","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2133.1995.tb08667.x","article-title":"p53 immunoreactivity is uncommon in primary cutaneous lymphoma","volume":"132","author":"McGregor","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/jca.2920090108","article-title":"Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection","volume":"9","author":"Rook","year":"1994","journal-title":"J Clin Apheresis"},{"key":"10.3816\/CLM.2000.s.003_bib36","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1046\/j.1526-0968.1999.00142.x","article-title":"The North American experience with photopheresis","volume":"3","author":"Zic","year":"1999","journal-title":"Ther Apher"},{"key":"10.3816\/CLM.2000.s.003_bib37","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0190-9622(96)90683-0","article-title":"Photopheresis therapy for cutaneous Tcell lymphoma","volume":"35","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib38","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0190-9622(96)90119-X","article-title":"Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution","volume":"35","author":"Gottlieb","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.jidsp.5640188","article-title":"Photopheresis: clinical applications and mechanism of action","volume":"4","author":"Rook","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.3816\/CLM.2000.s.003_bib40","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00000421-199406000-00016","article-title":"Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response","volume":"17","author":"Vonderheid","year":"1994","journal-title":"Am J Clin Oncol"},{"key":"10.3816\/CLM.2000.s.003_bib41","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0360-3016(95)00073-8","article-title":"Systemic chemotherapy and extracorporeal photochemotherapy for T3 and T4 cutaneous T-cell lymphoma patients who have achieved a complete response to total skin electron beam therapy","volume":"32","author":"Wilson","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CLM.2000.s.003_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2133.1995.tb02485.x","article-title":"Cutaneous colonization with staphylococci influences the disease activity of Sezary syndrome: a potential role for bacterial superantigens","volume":"133","author":"Tokura","year":"1995","journal-title":"Br J Dermatol"},{"issue":"suppl 1","key":"10.3816\/CLM.2000.s.003_bib43","first-page":"16","article-title":"Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.3816\/CLM.2000.s.003_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0733-8635(05)70012-7","article-title":"Advances in the management of cutaneous T-cell lymphoma","volume":"16","author":"Sinha","year":"1998","journal-title":"Dermatol Clin"},{"key":"10.3816\/CLM.2000.s.003_bib45","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0889-8588(18)30060-1","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Olsen","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2000.s.003_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/107999099314117","article-title":"Retinoids synergize with interleukin-2 to augment IFN-gamma and interleukin-12 production by human peripheral blood mononuclear cells","volume":"19","author":"Fox","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.3816\/CLM.2000.s.003_bib47","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.003_bib48","first-page":"23a","article-title":"A phase 2 open-label study of recombinant human interleukin-12 (RHIL-12) in patients with stage IA, IB or IIA cutaneous T-cell lymphoma (CTCL)","volume":"19","author":"Duvic","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.3816\/CLM.2000.s.003_bib49","first-page":"15","article-title":"Treatment of cutaneous T cell lymphoma with retinoids","volume":"7","author":"Zackheim","year":"1998","journal-title":"Dermatologic Therapy"},{"key":"10.3816\/CLM.2000.s.003_bib50","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S0190-9622(96)90282-0","article-title":"Combined modality therapy for cutaneous T-cell lymphoma","volume":"34","author":"Duvic","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib51","first-page":"7","article-title":"Retinoid receptor selectivity: importance and clinical application in dermatology and other diseases","volume":"7","author":"Duvic","year":"1998","journal-title":"Dermatologic Therapy"},{"key":"10.3816\/CLM.2000.s.003_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0190-9622(96)80062-4","article-title":"Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients","volume":"34","author":"Zackheim","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2000.s.003_bib53","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1200\/JCO.1999.17.10.3117","article-title":"Pentostatin therapy of T-cell lymphomas with cutaneous manifestations","volume":"17","author":"Kurzrock","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2000.s.003_bib54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood.V84.3.733.733","article-title":"2-Chlorodeoxyadenosine therapy in patients with T-cell lymphoproliferative disorders","volume":"84","author":"O'Brien","year":"1994","journal-title":"Blood"},{"key":"10.3816\/CLM.2000.s.003_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/(SICI)1096-8652(199805)58:1<87::AID-AJH18>3.0.CO;2-2","article-title":"DAB389IL2 diphtheria fusion toxin produces clinical responses in tumor stage cutaneous T cell lymphoma","volume":"58","author":"Duvic","year":"1998","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2000.s.003_bib56","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3816\/CLM.2000.n.012","article-title":"Enterococcal eschars in cutaneous T-cell lymphoma tumors: a distinct clinical entity","volume":"1","author":"Duvic","year":"2000","journal-title":"Clin Lymphoma"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511702731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511702731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T06:41:48Z","timestamp":1588920108000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511702731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":56,"alternative-id":["S1526965511702731"],"URL":"https:\/\/doi.org\/10.3816\/clm.2000.s.003","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}